Short Course Terlipressin for Control of Acute Variceal Bleeding
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 24 hours of Terlipressin is as effective as
72 hours of Terlipressin in preventing re-bleed once esophageal variceal bleed has been
controlled with endoscopic therapy (variceal band ligation or sclerotherapy) in low to
moderate risk variceal bleed patients and hence can save cost and may decrease length of
hospital stay especially in the I.C.U or high dependency units.